Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.

T G Woodworth; D E Furst; V Strand; J Kempeni; H Fenner; C S Lau; F Miller; R Day; J Lipani; P Brooks

Main menu

Home
Content
Resources
Subscribers
About Us
Contact Us

JRheum Supplements
Services

User menu

My Cart
Log In

Search

Search for this keyword

Advanced search

JRheum Supplements
Services

My Cart
Log In

Search for this keyword

Advanced Search

Home
Content
Resources
Subscribers
About Us
Contact Us

Follow Jrheum on BlueSky
Follow jrheum on Twitter
Visit jrheum on Facebook
Follow jrheum on LinkedIn
Follow jrheum on YouTube
Follow jrheum on Instagram
Follow jrheum on RSS

Abstract

Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.

T G Woodworth, D E Furst, V Strand, J Kempeni, H Fenner, C S Lau, F Miller, R Day, J Lipani and P Brooks

The Journal of Rheumatology May 2001, 28 (5) 1163-1169;

T G Woodworth

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

D E Furst

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

V Strand

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J Kempeni

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

H Fenner

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

C S Lau

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

F Miller

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

R Day

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J Lipani

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

P Brooks

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
References
PDF
eLetters

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 28, Issue 5

1 May 2001

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Standardizing assessment of adverse effects in rheumatology clinical trials. Status of OMERACT Toxicity Working Group March 2000: towards a common understanding of comparative toxicity/safety profiles for antirheumatic therapies.